mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
CBB-1007 |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.6 |
mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
BRD-K27188169 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.6 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.6 |